Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-029294
Filing Date
2024-12-13
Accepted
2024-12-13 16:20:17
Documents
1
Period of Report
2024-12-12

Document Format Files

Seq Description Document Type Size
1 form4-12132024_091213.html 4  
1 form4-12132024_091213.xml 4 3902
  Complete submission text file 0001415889-24-029294.txt   5679
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Issuer) CIK: 0000812796 (see all company filings)

EIN.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 7901 SPRINGER ROAD BETHESDA MD 20817
Business Address
RUBIN ROBERT J. (Reporting) CIK: 0001413631 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14778 | Film No.: 241548645